Stephens Inc Zoetis Inc. Transaction History

Stephens Inc

$6.84 Billion
Q4 2024

A detailed history of Stephens Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Stephens Inc holds 59,025 shares of ZTS stock, worth $10.3 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

59,025

Previous 48,344 22.09%

Holding current value

$10.3 Million

Previous $9.45 Million 1.81%

% of portfolio

0.14%

Previous 0.14%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	BUY	$162.24 - $194.42 $1.73 Million - $2.08 Million	10,681 Added 22.09%	59,025 $9.62 Million
Q3 2024 Oct 28, 2024	SELL	$172.58 - $196.48 $204,852 - $233,221	-1,187 Reduced 2.4%	48,344 $9.45 Million
Q2 2024 Aug 06, 2024	BUY	$145.54 - $178.83 $774,563 - $951,733	5,322 Added 12.04%	49,531 $8.59 Million
Q1 2024 May 15, 2024	BUY	$165.67 - $199.94 $362,982 - $438,068	2,191 Added 5.21%	44,209 $7.48 Million
Q4 2023 Feb 13, 2024	SELL	$151.44 - $200.09 $47,552 - $62,828	-314 Reduced 0.74%	42,018 $8.29 Million
Q3 2023 Nov 14, 2023	SELL	$167.14 - $192.77 $2.26 Million - $2.61 Million	-13,541 Reduced 24.24%	42,332 $7.36 Million
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $99,782 - $115,462	620 Added 1.12%	55,873 $9.62 Million
Q1 2023 May 15, 2023	SELL	$145.48 - $175.02 $725,945 - $873,349	-4,990 Reduced 8.28%	55,253 $9.2 Million
Q4 2022 Jan 25, 2023	SELL	$131.14 - $157.47 $427,647 - $513,509	-3,261 Reduced 5.14%	60,243 $8.83 Million
Q3 2022 Nov 02, 2022	SELL	$148.29 - $182.55 $16,460 - $20,263	-111 Reduced 0.17%	63,504 $9.42 Million
Q2 2022 Aug 03, 2022	SELL	$155.97 - $200.09 $273,103 - $350,357	-1,751 Reduced 2.68%	63,615 $10.9 Million
Q1 2022 May 04, 2022	SELL	$181.39 - $234.03 $3.72 Million - $4.8 Million	-20,490 Reduced 23.87%	65,366 $12.3 Million
Q4 2021 Mar 07, 2022	SELL	$193.69 - $247.03 $745,900 - $951,312	-3,851 Reduced 4.29%	85,856 $21 Million
Q3 2021 Oct 27, 2021	SELL	$189.29 - $209.69 $3.33 Million - $3.69 Million	-17,596 Reduced 16.4%	89,707 $17.4 Million
Q2 2021 Aug 12, 2021	BUY	$155.9 - $187.99 $168,839 - $203,593	1,083 Added 1.02%	107,303 $20 Million
Q1 2021 May 14, 2021	BUY	$144.0 - $169.39 $263,232 - $309,644	1,828 Added 1.75%	106,220 $16.7 Million
Q4 2020 Feb 10, 2021	BUY	$157.07 - $174.35 $438,382 - $486,610	2,791 Added 2.75%	104,392 $17.3 Million
Q3 2020 Nov 13, 2020	BUY	$137.1 - $165.37 $193,173 - $233,006	1,409 Added 1.41%	101,601 $16.8 Million
Q2 2020 Aug 24, 2020	BUY	$111.92 - $142.53 $272,525 - $347,060	2,435 Added 2.49%	100,192 $13.7 Million
Q1 2020 May 14, 2020	BUY	$92.66 - $144.94 $176,424 - $275,965	1,904 Added 1.99%	97,757 $11.5 Million
Q4 2019 Feb 14, 2020	SELL	$116.25 - $133.25 $91,256 - $104,601	-785 Reduced 0.81%	95,853 $12.7 Million
Q3 2019 Oct 18, 2019	BUY	$112.57 - $128.43 $117,297 - $133,824	1,042 Added 1.09%	96,638 $12 Million
Q2 2019 Aug 01, 2019	BUY	$97.98 - $114.28 $63,197 - $73,710	645 Added 0.68%	95,596 $10.8 Million
Q1 2019 May 03, 2019	BUY	$81.56 - $100.67 $1.1 Million - $1.36 Million	13,495 Added 16.57%	94,951 $9.56 Million
Q4 2018 Feb 11, 2019	BUY	$79.28 - $95.27 $398,461 - $478,827	5,026 Added 6.58%	81,456 $6.97 Million
Q3 2018 Nov 14, 2018	BUY	$83.5 - $93.23 $287,073 - $320,524	3,438 Added 4.71%	76,430 $7 Million
Q2 2018 Aug 10, 2018	BUY	$79.9 - $89.2 $17,657 - $19,713	221 Added 0.3%	72,992 $6.22 Million
Q1 2018 May 03, 2018	BUY	$71.51 - $84.69 $2.65 Million - $3.14 Million	37,103 Added 104.02%	72,771 $6.08 Million
Q4 2017 Feb 05, 2018	BUY	$63.24 - $72.8 $974,148 - $1.12 Million	15,404 Added 76.02%	35,668 $2.57 Million
Q3 2017 Nov 08, 2017	BUY	$59.73 - $65.4 $98,614 - $107,975	1,651 Added 8.87%	20,264 $1.29 Million
Q2 2017 Aug 10, 2017	BUY	N/A	18,613	18,613 $1.16 Million

Others Institutions Holding ZTS

# of Institutions

1,969

Shares Held

413M

Call Options Held

1.01M

Put Options Held

1.08M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $81.5B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account